Dr Reem Saleh
Honorary Fellow
The Sir Peter MacCallum Department of Oncology
44 Scholarly works
1 Projects
HIGHLIGHTS
2024
Research grants (other domestic)
The Biology of Melanoma Organ-Specific Metastases and Response to Therapy
2018
Journal article
CSF-1 in inflammatory and arthritic pain development
DOI: 10.4049/jimmunol.18006652018
Journal article
CCL17 blockade as a therapy for osteoarthritis pain and disease
DOI: 10.1186/s13075-018-1560-92018
Journal article
TNF and granulocyte macrophage-colony stimulating factor interdependence mediates inflammation via CCL17
DOI: 10.1172/jci.insight.992492018
Book Chapter
Cytokine-induced acute inflammatory monoarticular arthritis
DOI: 10.1007/978-1-4939-7837-3_202017
Journal article
G-CSF receptor blockade ameliorates arthritic pain and disease
DOI: 10.4049/jimmunol.16021272016
Journal article
Granulocyte macrophage colony-stimulating factor induces CCL17 production via IRF4 to mediate inflammation
DOI: 10.1172/JCI87828
RECENT SCHOLARLY WORKS
2025
Journal article
Sensitivity to immune checkpoint inhibitors in BRAF/MEK inhibitor refractory melanoma
DOI: 10.1136/jitc-2025-0115512025
Journal article
BRAF/MEK inhibition following immune checkpoint inhibitors promotes antitumor immunity associated with expansion of progenitor-exhausted CD8⁺ T cells
DOI: 10.1016/j.ejcskn.2025.1007372024
Journal article
Intra- and inter-tumoral heterogeneity of melanoma across different metastatic sites
DOI: 10.1158/1538-7445.TUMBODY-B0012024
Journal article
Single cell RNA-sequencing coupled with lineage tracing identifies novel clonal populations associated with immunotherapy resistance
DOI: 10.1158/1538-7445.TUMBODY-C0442023
Journal article
Editorial: Recent advances and challenges in cancer immunotherapies for patients with autoimmune diseases
DOI: 10.3389/fimmu.2022.11277392022
Journal article
Modelling aggressive prostate cancers of young men in immune-competent mice, driven by isogenic Trp53 alterations and Pten loss
DOI: 10.1038/s41419-022-05211-y2022
Journal article
Targeting MDM4 as a Novel Therapeutic Approach in Prostate Cancer Independent of p53 Status
DOI: 10.3390/cancers141639472022
Book Chapter
Lag3: From Bench to Bedside
DOI: 10.1007/978-3-030-96376-7_6